UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 285

Sortiert nach

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Clinical infectious diseases, 2015-05, Vol.60 (9), p.1295-1303

2015

Link zum Volltext

Verfügbarkeit prüfen

Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia

Clinical infectious diseases, 2022-09, Vol.75 (4), p.710-714

2022

Link zum Volltext

Verfügbarkeit prüfen

Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment

PloS one, 2016-04, Vol.11 (4), p.e0153247-e0153247

2016

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies

Antimicrobial agents and chemotherapy, 2023-06, Vol.67 (6), p.e0052623-e0052623

2023

Link zum Volltext

Verfügbarkeit prüfen

Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature

Diagnostic microbiology and infectious disease, 2019-11, Vol.95 (3), p.114856-114856, Article 114856

2019

Link zum Volltext

Verfügbarkeit prüfen

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4862-4869

2012

Link zum Volltext

Verfügbarkeit prüfen

Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria

PloS one, 2017-03, Vol.12 (3), p.e0173286

2017

Link zum Volltext

Verfügbarkeit prüfen

Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia

BMC infectious diseases, 2021-06, Vol.21 (1), p.1-572, Article 572

2021

Link zum Volltext

Verfügbarkeit prüfen

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa

Journal of clinical microbiology, 2018-02, Vol.56 (2)

2018

Link zum Volltext

Verfügbarkeit prüfen

Abdominal candidiasis is a hidden reservoir of echinocandin resistance

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7601-7605

2014

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients

Antimicrobial agents and chemotherapy, 2020-01, Vol.64 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA

Microbiology spectrum, 2021-12, Vol.9 (3), p.e0177921

2021

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients

PloS one, 2012-12, Vol.7 (12), p.e52349-e52349

2012

Link zum Volltext

Verfügbarkeit prüfen

Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3528-3535

2013

Link zum Volltext

Verfügbarkeit prüfen

Progress and New Challenges in Combatting the Threat of Antimicrobial Resistance: Perspective From an Infectious Diseases Pharmacist

The Journal of infectious diseases, 2024-02, Vol.229 (2), p.303-306

Shields, Ryan K

2024

Link zum Volltext

Verfügbarkeit prüfen

Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2371-2377

2012

Link zum Volltext

Verfügbarkeit prüfen

Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?

Antimicrobial agents and chemotherapy, 2020-03, Vol.64 (4)

Shields, Ryan K

2020

Link zum Volltext

Verfügbarkeit prüfen

Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase–Producing Gram-Negative Bacteria?

Clinical infectious diseases, 2020-08, Vol.71 (4), p.1099-1101

2020

Link zum Volltext

Verfügbarkeit prüfen

Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia

mBio, 2024-03, Vol.15 (3), p.e0339623-e0339623

2024

Link zum Volltext

Verfügbarkeit prüfen

Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185

mBio, 2024-02, Vol.15 (2), p.e0287423-e0287423

2024

Link zum Volltext

Verfügbarkeit prüfen

Mutations of the ompK36 Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5258-5265

2013

Link zum Volltext

Verfügbarkeit prüfen

Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysis

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-01, Vol.28 (1), p.87-90

2022

Link zum Volltext

Verfügbarkeit prüfen

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6361-6365

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(269)

Publikationsform

Sprache

Englisch
(285)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Life Sciences & Biomedicine
(179)
Microbiology
(122)
Humans
(120)
Pharmacology & Pharmacy
(79)
Infectious Diseases
(75)
Microbial Sensitivity Tests
(55)
Female
(54)
Male
(51)
Adult
(47)
Middle Aged
(47)
Anti-Bacterial Agents - Pharmacology
(45)
Aged
(38)
Anti-Bacterial Agents - Therapeutic Use
(38)
Immunology
(36)
Retrospective Studies
(30)
Biological And Medical Sciences
(29)
Klebsiella Pneumoniae
(28)
Medical Sciences
(28)
Abstracts
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae

Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia

Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment

Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies

Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria

Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa

Abdominal candidiasis is a hidden reservoir of echinocandin resistance

Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients

In Vitro Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA

Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients

Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure

Progress and New Challenges in Combatting the Threat of Antimicrobial Resistance: Perspective From an Infectious Diseases Pharmacist

Evolution of Outbreak-Causing Carbapenem-Resistant Klebsiella pneumoniae ST258 at a Tertiary Care Hospital over 8 Years

Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity

Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?

Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase–Producing Gram-Negative Bacteria?

Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia

Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185

Mutations of the ompK36 Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin

Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysis

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance

Suchergebnisse filtern